Feverfew (Tanacetum parthenium) is a plant of the daisy family that claims new uses with each passing year. The herb got its name from the Latin Febrifugia, which means “fever reducer” and it was first described as a remedy to treat “all hot inflammations” (Pareek et al., 2011). In the discussion forum, we discussed feverfew’s prophylactic role in migraine treatment. The herb is also renowned as a treatment for asthma, psoriasis, dizziness and allergy in addition to a host of other applications.
The mechanism of action relative to feverfew is expressed through inhibitory functions that prevent certain chemical reactions from taking place within the body. As outlined in the remarkable work of Pareek et al. (2011), in many instances, a chain reaction of events, if not disrupted, leads to manifestations of pain and inflammation. Feverfew’s chemical compounds have anti-cancer, chemotherapeutic, and anti-inflammatory properties. They inhibit histamine release; they inhibit the growth of bacterial and fungi. They inhibit serotonin release from platelets, among others. The herb disrupts prostaglandin synthesis leading to reduced inflammation. Research further supports the work of feverfew as an inhibitor of various processes related to the manifestation of rabbit aorta. Experts believe its effect as an inhibitor is aided by its ability to suppress channels dedicated to the flow of potassium. As these networks are clogged or blocked, the smooth muscles in the body are permitted to return to states of relaxation and to resist the onset of disorders, fevers and inflammatory responses. Due to its mechanisms of action, which unfolds through inhibitive processes, the herb promises better health for millions.
Pareek, A., Suthar, M., Rathore, G.S. & Bansal, V. (2011). Feverfew (Tanacetum parthenium L.): A systematic review. Pharmacognosy Review, 5(9), 103-110. https://doi.org/10.4103/0973-7847.79105